CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,000 enrolled
Drug / intervention
Whole Slide Imaging +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03991468
NCT03991468N/ACompleted

Clinical Validation for Non-Inferiority of Primary Diagnosis by WSI Hamamatsu NanoZoomer S360MD Digital Slide Scanner System Compared to Conventional Determination by Light Microscope

Hamamatsu Photonics K.K.·interventional·Posted Jun 19, 2019·Updated Dec 22, 2022

In Brief

A clinical study evaluating Whole Slide Imaging and Light Microscopy for Pathology. Completed, enrolled 2,000 participants across 4 sites.

Detailed Summary

The primary objective of this study is to evaluate the safety and accuracy of the Hamamatsu WSI compared to those of the reference method (conventional light microscope (Glass)) under clinical use conditions as an aid for pathologists to view, review and diagnose digital images of surgical pathology slides. The primary endpoint is the indicator of major discordance in primary diagnosis between ground truth case diagnosis and case diagnosis by each modality, WSI and Glass, separately.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPathology
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJun 19, 2019
Enrollment StartMar 15, 2019
Primary CompletionJul 31, 2021
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 7.0 years ago

Interventions

Whole Slide Imagingother

Scanning of a glass slide to create a digital image that can be viewed on a monitor

Light Microscopyother

Use of traditional light microscopy per institutional standard practice